Leave your message or request below and we will get back to you as soon as possible.
vNKT clinical trial · patient screening form
We are conducting a clinical study on vNKT immunotherapy. This form is for preliminary screening only; saving it does not mean enrollment. Information is used for screening only; separate informed consent will be signed before formal enrollment.
Part 1: Basic information
2. Sex
years
4. Nationality
Part 2: Disease and medical history
9. Treatments received (multiple choice)
10. Performance status (ECOG reference)
Part 3: Initial screening criteria
11. Are you 18 years of age or older?
12. Are you willing to participate and able to sign informed consent?
13. Known severe allergy, especially to biological products or monoclonal antibodies?
14. Active, uncontrolled severe infection (e.g. HBV, HCV, HIV, syphilis)?
15. Severe uncontrolled cardiac disease (e.g. NYHA III–IV), lung disease, or other major organ dysfunction?
16. Active autoimmune disease or need for systemic immunosuppression?
17. Pregnant or breastfeeding?
18. Participated in another drug or device trial within the past 6 months?
Part 4: Self-report and additional information
20. What do you hope to achieve through this immunotherapy study? (multiple choice)
Tip: For extensive records, you may contact the clinical study coordinator to submit pathology, imaging, or discharge summaries.
Declaration
Privacy Policy
Thank you for trusting LEHE MedNeo. This Privacy Policy explains how we collect, use, store and protect your personal information.
1. Information We Collect
When you submit the contact form, message form, or patient screening form on this website, we collect the information you voluntarily provide, including your name, contact details (mobile / WeChat / email), city, inquiry intent, and any health-related answers in the screening form.
2. How We Use Your Information
Your information is used solely for:
Responding to your inquiry;
Arranging consultation, follow-up or clinical-study enrollment communication;
Internal statistics and service improvement, within the scope permitted by law.
3. Information Protection
We protect your personal information through encrypted transmission, minimized access permissions and regular security audits. Your information will not be disclosed or shared with any unrelated third party without your explicit consent.
4. Your Rights
You have the right to access, correct or request deletion of the personal information we hold about you. To exercise these rights, please contact us using the channels listed on this page.
LEHE MedNeo reserves the right of final interpretation of this Privacy Policy. Please edit this content in the backend under the "Privacy Policy" sidebar menu.
Lung Cancer
"Anti-cancer Special Force vNKT" is emerging as a rising star in China's immunology community.